anmelden
Novartis Aktie
134,12
EUR
+3,74
EUR
+2,87
%
133,86
EUR
+3,24
EUR
+2,48
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 29.10.12 | Novartis halten | Independent Research GmbH | |
| 16.10.12 | Novartis neutral | Citigroup Corp. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
|
Werbung
|
|||
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 25.06.12 | Novartis neutral | UBS AG | |
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 18.05.12 | Novartis hold | Vontobel Research | |
| 04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
| 03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.05.12 | Novartis hold | Vontobel Research | |
| 30.04.12 | Novartis hold | Vontobel Research | |
| 25.04.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 25.04.12 | Novartis hold | Vontobel Research | |
| 24.04.12 | Novartis halten | Independent Research GmbH | |
| 24.04.12 | Novartis hold | Vontobel Research | |
| 10.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 16.03.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 07.03.12 | Novartis neutral | J.P. Morgan Cazenove | |
Werbung
Werbung